Venus: Phase IV of Baddi project

MUMBAI: Venus Remedies has completed Phase IV of the Baddi project comprising two dedicated plants for specialty formulations, one for pre-filled injectible filling in glass syringes and a dedicated plant for hormones in injections and put under validation runs and trial production.

These new plants will broad-base the company’s product profile with the addition of hormones and heparins.

The PFS facility has a production capacity of 10,000 pieces per day in single shift while the hormones plant has capacity of 25,000 pieces per day. With this, all eight plants for dedicated manufacturing of Cephalosporins, Carbapenems, Oncology Liquid, Oncology Lyophilied, PFS, Hornioness, SVP in ampoules and injections in liquid vials have been completed, well ahead of its scheduled target for December 2007.

Six of these plants have been put into commercial operations as on date and by the end of this quarter, all the eight sections would be in commercial operation.

The Venus Remedies share was up 2.33% at Rs 469.40 on the Bombay Stock Exchange.